Ligand Pharmaceuticals Inc
F:LGDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Ligand Pharmaceuticals Inc
F:LGDN
|
US |
|
R
|
Ralph Lauren Corp
XBER:PRL
|
US |
|
S
|
SoftBank Group Corp
XMUN:SFT
|
JP |
|
A
|
Ageas SA
XMUN:FO4N
|
BE |
|
Full Truck Alliance Co Ltd
NYSE:YMM
|
CN |
|
R
|
Randstad NV
F:RSH
|
NL |
|
R
|
Renasant Corp
XBER:RN6
|
US |
|
C
|
Comtech Telecommunications Corp
XMUN:CC6
|
US |
|
Cerebras Systems Inc.
NASDAQ:CBRS
|
US |
|
Anglogold Ashanti PLC
F:HT3
|
UK |
|
Bank of Communications Co Ltd
OTC:BKFCF
|
CN |
|
China Merchants Bank Co Ltd
F:M4BB
|
CN |
|
P
|
Pruksa Holding PCL
SET:PSH
|
TH |
|
W
|
Wilmar International Ltd
XMUN:RTHA
|
SG |
|
C
|
Chipotle Mexican Grill Inc
XMUN:C9F
|
US |
|
WhiteHorse Finance Inc
NASDAQ:WHF
|
US |
Wall St Price Targets
LGDN Price Targets Summary
Ligand Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
LGDN is 192.65 EUR with a low forecast of 156.14 EUR and a high forecast of 243.49 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LGDN's stock price target?
Price Target
192.65
EUR
According to Wall Street analysts, the average 1-year price target for
LGDN is 192.65 EUR with a low forecast of 156.14 EUR and a high forecast of 243.49 EUR.
What is the Revenue forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 13%.
What is the Operating Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
29%
Over the last 14 years, the compound annual growth rate for Operating Income has been 26%. The projected CAGR for the next 8 years is 29%.
What is the Net Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 7 years is 17%.